We're sorry but the Program doesn't work properly without JavaScript enabled. Please enable it to continue.
Horizontal
Vertical
List
Program
Chairs & Speakers
Favourites
Download Program
Help
Event Times (GMT+1)
Local Times (GMT+2)
Login
Session Groups
Session Types
Networking
Data Blitz Session
Spotlight Session
Symposium
Meet the Experts / Campfire Session
Plenary
Break
Session
Industry
Posters
Featured Communication
Rooms
Back
Sarah Catherine Gillard
University of Edinburgh, Edinburgh, United Kingdom
In presentations
Sunday, June 28, 01:20 PM – 01:20 PM
Chronic oral administration of sertraline, alprazolam, or quetiapine modifies the excitatory synaptome architecture in mice
Speaker: Sarah Catherine Gillard (University of Edinburgh, Institute for Neuroscience and Cardiovascular Research (INCR), Edinburgh, United Kingdom)
